Endothelial activation and injury by microparticles in patients with systemic lupus erythematosus and rheumatoid arthritis

• Published in: Arthritis research & therapy 2019-01, Vol.21 (1), p.34-34, Article 34
• Main Authors: Atehortúa, Laura, Rojas, Mauricio, Vásquez, Gloria, Muñoz-Vahos, Carlos H, Vanegas-García, Adriana, Posada-Duque, Rafael Andrés, Castaño, Diana
• Format: Article
• Language: English
• Subjects: Antigens, CD - immunology; Antigens, CD - metabolism; Apoptosis; Arthritis; Arthritis, Rheumatoid - immunology; Arthritis, Rheumatoid - metabolism; Arthritis, Rheumatoid - pathology; Atherosclerosis; Autoimmune diseases; Cadherins - immunology; Cadherins - metabolism; Cardiovascular disease; Cell Adhesion - immunology; Cell Membrane Permeability - immunology; Cell-Derived Microparticles - immunology; Cell-Derived Microparticles - metabolism; Cells, Cultured; Chemokines; Chemokines - immunology; Chemokines - metabolism; Cytokines - immunology; Cytokines - metabolism; DNA methylation; Endothelial cells; Endothelial Cells - immunology; Endothelial Cells - metabolism; Endothelium; Endothelium - immunology; Endothelium - metabolism; Endothelium - pathology; Flow Cytometry; Fluorescence microscopy; Humans; Immune complexes; Inflammation; Lupus; Lupus Erythematosus, Systemic - immunology; Lupus Erythematosus, Systemic - metabolism; Lupus Erythematosus, Systemic - pathology; Microparticles; Microscopy, Fluorescence; Monocytes - immunology; Monocytes - metabolism; Nitric oxide; Permeability; Rheumatoid arthritis; Systemic lupus erythematosus
• ISSN: 1478-6362; 1478-6354; 1478-6362
• DOI: 10.1186/s13075-018-1796-4

Endothelial activation and damage is commonly observed in patients with systemic lupus erythematosus (SLE) and rheumatoid arthritis (RA) and is related to development of atherosclerosis and cardiovascular diseases. Different components of the immune system seem to participate in the endothelial injury, such as generation of autoantibodies and formation of immune complexes (ICs). Microparticles (MPs) and their immune complexes (MPs-ICs) are increased in the circulation of patients with SLE and RA; therefore, we propose these extracellular vesicles could interact and modulate the function of endothelial cells. Hence, the effect of MPs and MPs-ICs from patients with SLE and RA in endothelial cells was evaluated. Macrovascular and microvascular endothelial cells were exposed to MPs and MPs-ICs from healthy donors and patients with SLE and RA. Vesicles uptake/binding, expression of adhesion molecules, cytokine and chemokine production, monocyte adherence, and alterations of endothelial monolayer were evaluated by flow cytometry and fluorescence microscopy. Endothelial cells internalized MPs and MPs-ICs and increased CD54 and CD102 expression and CCL2, CCL5, and IL-6 production after the treatment with these extracellular vesicles, which led to an increase in the adherence of classic monocytes. These vesicles also induced low expression of VE-cadherin in membrane, depolymerization of actin filaments, and formation of intercellular spaces, which led to endothelial death and increased permeability after MPs and MPs-ICs exposure. MPs and MPs-ICs from patients with SLE and RA increase adhesion molecules expression, chemokine production, and structural alterations in macrovascular and microvascular endothelial cells. Therefore, high counts of these vesicles in patients would promote endothelial alterations and secondary tissue leukocyte infiltration.